1. Telix mediarelease27October2022. 2. ASXdisclosure14November2022. 3. Telixsocialmedia21December 2022. AboutTelix PharmaceuticalsLimited Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals.TelixisheadquarteredinMelbourne, Australia withinternationaloperationsinUnitedStates, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of clinical-stage products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX). For more information visit www.telixpharma.comand follow Telix on LinkedIn. TLX250-CDx(89Zr-DFO-girentuximab)hasnotreceived amarketingauthorisationinanyjurisdiction.Telix'sleadproduct, Illuccixorkitforpreparationofgallium-68(68Ga)gozetotide(also knownas68GaPSMA-11)injection, hasbeenapproved by the U.S. Food and Drug Administration (FDA), 1 by the Australian Therapeutic Goods Administration (TGA), 2 and by Health Canada.3 TelixInvestor Relations Ms.KyahnWilliamson TelixPharmaceuticalsLimited SVPCorporateCommunicationsandInvestorRelations Email: [email protected] ThisannouncementhasbeenauthorisedforreleasebytheTelix PharmaceuticalsLimitedDisclosureCommitteeonbehalf of the Board. Legal Notices Thisannouncementisnotintended aspromotionoradvertisingdirected toanyhealthcareprofessionalorotheraudience in any country worldwide (including Australia, United States and the United Kingdom). This announcement may include forward-looking statements that relate to anticipated future events, financial performance, plans, strategies or business developments.Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "outlook", "forecast" and"guidance", orothersimilar words.Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on the Company's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect the Company's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but arenotlimitedto, statementsabout: theinitiation, timing, progressandresults ofTelix'spreclinicalandclinicalstudies, andTelix's researchanddevelopmentprograms;Telix'sability toadvanceproduct candidatesinto, enrol andsuccessfully complete, clinical studies, includingmulti-nationalclinicaltrials;thetimingorlikelihoodofregulatoryfilings andapprovals, manufacturing activities and product marketing activities; the commercialisation of Telix's product candidates, if or when theyhavebeenapproved;estimatesofTelix's expenses, futurerevenuesandcapitalrequirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may beadverse.Accordingly, youshouldnotplaceunduerelianceontheseforward-lookingstatements.Youshould read this announcement together with our risk factors, as disclosed in our most recently filed reports with the ASX or on our website. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to publicly update or revise any forward-lookingstatementscontained inthisannouncement, whetherasaresult ofnewinformation, futuredevelopments or a change in expectations or assumptions. TheTelix PharmaceuticalsandtheIlluccixnameandlogoaretrademarksofTelixPharmaceuticalsLimitedanditsaffiliates - all rights reserved. 1. ASXdisclosure20December2021. 2. ASXdisclosure2November2021. 3. ASXdisclosure14October2022 "/>

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.

More Information
null in null

Southeast Asia

Section
UN Demands End to Myanmar Violence as Junta’s Election Plans Risk Further Instability
UN Demands End to Myanmar Violence as Junta’s Election Plans Risk Further Instability

Nearly three months after a devastating earthquake struck Myanmar, the country remains trapped in a deepening crisis, compounded by...

Earthquake of 4.1 magnitude strikes Myanmar
Earthquake of 4.1 magnitude strikes Myanmar

Naypyidaw [Myanmar], July 3 (ANI): An earthquake of magnitude 4.1 struck Myanmar on Thursday, a statement by the National Center for...

Xi Jinping champions the cause of Global South
Xi Jinping champions the cause of Global South

by Xinhua writer Jiang Hanlu BEIJING, July 3 (Xinhua) -- On the banks of the shimmering Huangpu River that cuts through the Chinese...

Vaibhav Suryavanshi cracks 31-ball 86 against England U19, narrowly misses Pant's record
Vaibhav Suryavanshi cracks 31-ball 86 against England U19, narrowly misses Pant's record

Northampton [UK], July 3 (ANI): The 14-year-old Indian batting sensation Vaibhav Suryavanshi fell just short of Rishabh Pant's record...

"Not going to let this Communist Lunatic destroy New York": Trump again takes a dig at NYC Dem primary Mamdani
"Not going to let this Communist Lunatic destroy New York": Trump again takes a dig at NYC Dem primary Mamdani

Washington, DC [US], July 2 (ANI): US President Donald Trump was yet again at his rhetoric against the Democratic mayoral nominee for...

Seminar held in national capital focusing prospects of Artificial Intelligence in Northeast region
Seminar held in national capital focusing prospects of Artificial Intelligence in Northeast region

New Delhi [India], July 2 (ANI): A seminar on the prospects and possibilities of artificial intelligence in Northeast India was organised...

Business

Section
Wall Street diverges, but techs advance Wednesday
Wall Street diverges, but techs advance Wednesday

NEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...

Greenback slides amid tax bill fears, trade deal uncertainty
Greenback slides amid tax bill fears, trade deal uncertainty

NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...

Taliban seeks tourism revival despite safety, rights concerns
Taliban seeks tourism revival despite safety, rights concerns

KABUL, Afghanistan: Afghanistan, long associated with war and instability, is quietly trying to rebrand itself as a destination for...

Nvidia execs sell $1 billion in stock as AI boom drives record prices
Nvidia execs sell $1 billion in stock as AI boom drives record prices

SANTA CLARA, California: Executives at Nvidia have quietly been cashing in on the AI frenzy. According to a report by the Financial...

Tech stocks slide, industrials surge on Wall Street
Tech stocks slide, industrials surge on Wall Street

NEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...

Canada-US trade talks resume after Carney rescinds tech tax
Canada-US trade talks resume after Carney rescinds tech tax

TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...